Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05723328 · ClinicalTrials.gov registry record · NA
Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma
A NA study, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05723328: Clinical Trial NA study, sponsored by Hackensack Meridian Health.
NCT05723328 is a NA study that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05723328, a NA study, was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will use a systematic music therapy intervention on patients with mental illness trying to help them with their internalized stigma.
Primary Outcome
The Internalized Stigma of Mental Illness Inventory will be administered before and after the MTAR intervention and the change in the score will be reported. Primary outcome will be reported only for the treatment arm. The internalized stigma of mental illness inventory is a 29 item questionnaire. Items are scored on a 1-4 scale, with the total scale score calculated as a sum of the items then dividing by the total number of answered items.
Interventions
- BEHAVIORAL Group Music Therapy Advocacy Recording Intervention (MTAR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-04-25 |
| Est. Completion | 2023-04-26 |
| Phase | NA |
Why NCT05723328 stopped before completion
NCT05723328 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Group Music Therapy Advocacy Recording Intervention (MTAR) is the first listed.
NCT05723328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05723328 about?
NCT05723328 is a clinical study titled "Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma". This study will use a systematic music therapy intervention on patients with mental illness trying to help them with their internalized stigma.
What is the current status of trial NCT05723328?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2023-04-25. Estimated completion is 2023-04-26.
What interventions are being tested in trial NCT05723328?
The interventions under investigation include: Group Music Therapy Advocacy Recording Intervention (MTAR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05723328?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05723328's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI